Fried Frank acted as counsel to Finger Lakes Clinical Research (FLCR) in its acquisition by Evolution Research Group (ERG). FLCR is a clinical research facility specializing in pediatric and adult central nervous system trials for major national and international pharmaceutical firms. ERG, which is owned by Linden Capital Partners, is an independent clinical research site company serving pharmaceutical companies and clinical research organizations, with an expertise in early- and late-stage neuroscience drug development.
The Fried Frank team was led by corporate partner Philip Richter and included executive compensation & ERISA partner Adam Kaminsky, tax partner Michael J. Alter, corporate associates Liza Wehrly Andrews and Christopher S. Celentano, and tax associate Thomas A. Mitchell.